In continuation of the Company''s disclosure dated 19th February 2025, this is to inform you that Sudarshan Pharma Poland Limited Liability Company has been incorporated as a wholly-owned ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma has set up a 100% wholly-owned subsidiary called Sudarshan Pharma Poland Limited Liability Company, based in Warsaw, Poland. The company subscribed to 100 shares of Polish Zloty 50 each, totalling PLN 5,000 (approximately Rs. 1,30,000) for full ownership. This follows board approval from February 2025 and aims to expand the company's customer base in the European region. The Polish subsidiary's objects include manufacture of basic chemicals, fertilizers, plastics, pesticides, agrochemicals, cosmetics, and pharmaceutical wholesale.
The financial commitment is very small (around Rs. 1.3 lakh) so there is no material impact on the stock in the short term. However, this is a strategic step towards building a European footprint, which could support long-term revenue growth if the subsidiary gains traction.